Dr. Andrea Covelli is a surgical oncologist in the Division of General Surgery, Mount Sinai Hospital and an Assistant Professor and Surgeon-Investigator at the University of Toronto. Dr. Covelli’s clinical focus is the surgical management of complex skin malignancies and breast disease with a special interest in rare breast malignancies, including breast sarcomas.

She received her Medical Degree from the University of Western Ontario, and obtained both her residency training in General Surgery and her General Surgical Oncology fellowship training at the University of Toronto. Dr. Covelli is also an alumna of the Surgeon-Scientist and Clinician Investigator Program having completed her PhD in Clinical Epidemiology at the Institute of Health Management, Policy and Evaluation at the University of Toronto. Her research interests include improving patient and cancer care outcomes and addressing health inequities in cancer care for under-represented patient populations.

Dr. Alexandra Easson is an Associate Professor of Surgery at the University of Toronto. She specializes in the surgical treatment of cancer of the breast, melanoma and gastrointestinal tract. Her research uses her training in clinical epidemiology to study the clinical management of breast cancer. Her research interests include surgical perspectives on palliative medicine, clinical surgical oncology and sentinel lymph node biopsy.

Dr. Jaime Escallon received his medical degree from the University of El Rosario, Bogotá Colombia in 1974, came to Toronto and trained in the Gallie Program in General Surgery and became Fellow of the Royal College in 1981. He then went back to Colombia to practice General Surgery in an Academic Institution, the Fundacion Santa Fe de Bogota, where he was Head of the Division of General Surgery, Chair of the Department of Surgery and later Chief of Staff. In 2002 he was invited to come back to Toronto and offered the position of Head of General Surgery at the Toronto Western Hospital and Coordinator of the Breast Cancer program at the Marvelle Koffler Center at Mount Sinai Hospital. He was also Co-director of the General Surgery residency program at the University of Toronto and he has been involved with Cancer Care Ontario in the Surgical Oncology Program. Dr. Escallon has served in many editorial boards. His current interests are in education and breast cancer clinical research.

Dr. Wey Leong is an Assistant Professor, General Surgery. After his medical school at Dalhousie Medical School in 1994, Dr. Leong continued his General Surgery residency in Halifax during which time he also completed his master degree in Molecular Pathology. In year 2000, he moved to Toronto for his breast/melanoma surgical oncology fellowship. He became a Staff Surgical Oncologist at Princess Margaret Hospital and Mount Sinai Hospital 2 years later. He is currently an assistant professor at the University of Toronto. His research laboratory is within the Ontario Cancer Institute and his primary research interests include genetic epidemiology of breast cancer and novel techniques and technologies in the diagnosis of breast cancer and melanoma.

Dr. Christine Brezden-Masley is a practicing Medical Oncologist and the Director of the Marvelle Koffler Breast Centre at Mount Sinai Hospital as well as the Medical Director of Cancer Program for Sinai Health in Toronto, Canada. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the University of Toronto and senior scientist for the same Clinical Research Group at the Lunenfeld-Tanenbaum Research Institute for Sinai Health in Toronto, Canada.

Dr. Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and she has been the Co-Chair of the Annual Canadian Cardio-Oncology Network meeting, a collaborative national meeting improving cardiac heath in patients with cancer and is currently the President of the Canadian Cardio-Oncology Network.

Dr. Christine Elser is an Associate Professor of Medicine at the University of Toronto with appointments as Staff Medical Oncologist at Mount Sinai Hospital and Princess Margaret Hospital. Her specialist areas are breast cancer and cancer of unknown primary. She is the head of the Familial Breast Cancer Clinic at the Marvelle Koffler Breast Centre and provides risk reduction counselling and follow-up care for women with a strong family history of breast cancer. She is investigator in many breast cancer trials and involved in research on familial breast cancer. She is involved in teaching undergraduate student and residents and serves as member of the Medical Oncology training committee.

Dr. Pamela Goodwin is a Professor of Medicine at the University of Toronto, with a cross appointment in the Department of Public Health Sciences and in the School of Graduate Studies. She is a Senior Scientist in the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, and former Director of the hospital's Marvelle Koffler Breast Centre. Dr. Goodwin continues to be actively involved in broad range of research relating to breast cancer.

Dr. Geoffrey Watson is a Staff Medical Oncologist at Mount Sinai Hospital and an Assistant Professor of Medicine at the University of Toronto. He completed his basic and specialized training in medical oncology in Dublin, Ireland and joined the Drug Development and Sarcoma Programs at the Princess Margaret Cancer Centre as a clinical research fellow in 2019. During this time he served as the Chief Fellow of the Division of Medical Oncology and Hematology. During this time he was awarded with a Hold’em for Life Oncology Clinician Scientist Award in 2019, an ASCO Merit Award in 2020 and 2021 as well as the Novartis Oncology Young Canadian Investigator Award in 2020 and 2021. He has also received a Bachelor of Science degree in Computer Science as well as a Master’s degree in Pharmacological Bioinformatics at University College Dublin, Ireland. Dr. Watson’s clinical focus is on the treatment of sarcoma and breast cancer. His academic interest is in patient reported outcomes and quality of life, and he also has an interest in teaching and education, particularly the evolving role of virtual education. He is currently the Integrated Clinical Experience Year 1 (ICE-1) Site Coordinator at Mount Sinai Hospital and also serves on the Virtual Care Continuous Professional Development Committee at the University Health Network.

Dr. Jon Hunter is the psychiatrist who focuses on the psychosocial care of patients undergoing diagnosis and treatment for cancer. As the Head of the Consultation-Liaison Program in the Department of Psychiatry at Mount Sinai Hospital, he also teaches undergraduate and post-graduate students and conducts research. The research topics include: minimizing chemotherapy side-effects via pre-emptive relaxation training, psychological support for women in high-risk families and the possible interactions between early life experience and coping with illness. In the oncology program Dr. Hunter sees people for diagnosis and treatment of coping-related issues and distress in cancer, often in collaboration with social work, nursing and oncology colleagues.